This $377,227 Project Grant was awarded on August 15, 2024 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The prime awardee, Florida State University, will conduct research related to traumatic brain injury and psychological health. The funded project aims to develop innovative...
This $6,214,900 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports research on the role of genetic risk factors and immune response on neurovascular unit (NVU) function in post-traumatic brain injury (TBI) cognitive impairment. The primary awardee, the Scintillon Institute, a non-profit biomedical research organization in San Diego, California, will conduct this advanced scientific investigation over...
This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
This Project Grant award of $717,896.00 was provided by the Defense Health Agency to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420). The purpose of the award is to conduct research on prebiotic and probiotic interventions for the treatment of traumatic brain injury (TBI)-induced microbiome dysfunction. The Ohio State University is the prime awardee, and they have issued a $XXX,XXX subaward to the Research Institute at Nationwide Children's...
The Defense Health Agency awarded a $7,999,917 project grant under the Military Medical Research and Development (CFDA 12.420) program to The Research Foundation For The State University Of New York on behalf of Suny Downstate Health Sciences University. The four-year award beginning September 30, 2022 supports the "GAP-BASED MILIEU BIOMARKERS FOR TRAUMATIC BRAIN INJURY (GAMBIT-TBI)" program. Under the award, Suny Downstate and six sub-awardees - The Morehouse School Of Medicine, Inc.,...
The Defense Health Agency awarded a $725,000 Project Grant to the University of Oklahoma Health Sciences Center to develop treatments for cognitive, motor, and sensory outcomes associated with mild traumatic brain injury and post-traumatic stress disorder. Funded through the Military Medical Research and Development program under the Cooperative Agreements and Other Transactions authority, this three-year award beginning April 15, 2023 will support research into modulating the NOP receptor...
This $608,353 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a longitudinal study by Craig Hospital's Research Department on resilience-related factors influencing psychosocial growth after traumatic brain injury. The study, titled "THRIVING AFTER TBI: A LONGITUDINAL INVESTIGATION OF RESILIENCE-RELATED FACTORS FOR PSYCHOSOCIAL GROWTH AFTER TRAUMATIC BRAIN INJURY," will be conducted over a 3-year...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,314,065.00 to The Regents of the University of California, San Francisco (UCSF) to conduct research on the "Dose-Response Relationship of Acute TBI Blood Biomarkers with Pathoanatomic Neuroimaging Findings". The research aims to transform healthcare for military service members, veterans, and the broader public by advancing biomedical research on...
The University of Oklahoma received a $2,273,306 federal Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "NEUROPEPTIDE MODULATION OF CEREBRAL BLOOD FLOW TO IMPROVE NEUROLOGICAL AND PSYCHOLOGICAL OUTCOMES FOLLOWING TBI IN THE PRESENCE AND ABSENCE OF TRAUMATIC STRESS". The 4-year grant, which began on Jul 1, 2023, aims to investigate medical solutions for traumatic brain injuries (TBI) and the impacts...
This federal Project Grant award of $2,433,748.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the "DECISION SUPPORT TOOLS ADDRESSING TRAUMATIC BRAIN INJURY IN BRIDGE (STAT-BRIDGE)" research project. The grant was awarded on June 1, 2025 to The Regents of the University of California, San Francisco, a prominent academic medical center and research institution, with a performance period through May 31, 2029. The...